Document is current
Any future updates will be listed below
-
Authors
Montero, Alex R.
Toro-Tobon, David https://orcid.org/0000-0003-1910-4144
Gann, Kelly
Nassar, Carine M.
Youssef, Gretchen A.
Magee, Michelle F.
-
Funding
Funding for this research was provided by:
Medstar Health
BioTel
- License Information
-
More Information
Article History
Received: 4 March 2021
Accepted: 22 October 2021
First Online: 10 November 2021
Declarations
:
: The study was reviewed and approved by the MedStar Health Research Institute’s Institutional Review Board and was conducted from November 2014 to February 2018. Participants during the first 16 months provided written informed consent prior to enrollment. In July 2016, the MedStar Health Research Institute’s Institutional Review Board designated the study as a quality Improvement project and waived the informed consent requirement for further participants.
: Not applicable.
: Ms. Kelly Gann is a full-time employee at Biotelemetry, the maker of the blood glucose management system used in the study. Drs. Montero, Toro-Tobón and Magee, and Ms. Nassar and Ms. Youssef report no conflicts of interest relevant to this research.
